OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - PARNELL PHARMACEUT HLDGS LTD ownership

PARNELL PHARMACEUT HLDGS LTD's ticker is PARNF and the CUSIP is Q73622104. A total of 14 filers reported holding PARNELL PHARMACEUT HLDGS LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of PARNELL PHARMACEUT HLDGS LTD
ValueSharesWeighting
Q1 2015$386,000,000
-24.2%
78,681
-36.0%
0.01%
-11.1%
Q4 2014$509,000,000
-36.8%
122,900
-12.3%
0.01%
-35.7%
Q3 2014$806,000,000140,1000.01%
Other shareholders
PARNELL PHARMACEUT HLDGS LTD shareholders Q2 2015
NameSharesValueWeighting ↓
Endurant Capital Management LP 448,802$732,0000.24%
SABBY MANAGEMENT, LLC 389,400$635,0000.03%
ATWOOD & PALMER INC 16,900$28,0000.01%
Alyeska Investment Group, L.P. 147,458$240,0000.00%
AlphaMark Advisors, LLC 400$1,0000.00%
BLACKROCK ADVISORS LLC 572,696$933,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 36,800$60,0000.00%
Cambridge Investment Research Advisors, Inc. 10,000$16,0000.00%
Tower Research Capital LLC (TRC) 690$1,0000.00%
Creative Planning 2,000$3,0000.00%
View complete list of PARNELL PHARMACEUT HLDGS LTD shareholders